Michael Hayes, Ph.D.
Affiliations: | 1977- | Chemistry | Northeastern University, Boston, MA, United States |
Google:
"Michael Hayes"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sahebjam S, Tran ND, Yu HM, et al. (2015) ATNT-22A PHASE 1 STUDY OF TPI 287 CONCURRENT WITH FRACTIONATED STEREOTACTIC RADIOTHERAPY (FSRT) IN TREATMENT OF BRAIN METASTASES FROM ADVANCED BREAST AND NON-SMALL CELL LUNG (NSCL) CANCER Neuro-Oncology. 17: v15.3-v15 |
| Kim DW, Tan EY, Jin Y, et al. (2011) Effects of imatinib mesylate on the pharmacokinetics of paracetamol (acetaminophen) in Korean patients with chronic myelogenous leukaemia. British Journal of Clinical Pharmacology. 71: 199-206 |
| Yang Z, Ke J, Hayes M, et al. (2009) A sensitive and high-throughput LC-MS/MS method for the quantification of pegylated-interferon-alpha2a in human serum using monolithic C18 solid phase extraction for enrichment. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 877: 1737-42 |
| Guilhot F, Hughes TP, Cortes J, et al. (2008) Imatinib (IM) Pharmacokinetic (PK) Exposure and Its Correlation with Clinical Outcome in Patients with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) for 400 Mg and 800 Mg Daily Doses (Tyrosine Kinase Dose Optimization Study [TOPS]) Blood. 112: 447-447 |
| Yang Z, Hayes M, Fang X, et al. (2007) LC-MS/MS approach for quantification of therapeutic proteins in plasma using a protein internal standard and 2D-solid-phase extraction cleanup. Analytical Chemistry. 79: 9294-301 |
| Pollack IF, Jakacki RI, Blaney SM, et al. (2007) Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report. Neuro-Oncology. 9: 145-60 |
| Li W, Luo S, Hayes M, et al. (2007) Determination of N-methyl-4-isoleucine-cyclosporin (NIM811) in human whole blood by high performance liquid chromatography-tandem mass spectrometry. Biomedical Chromatography : Bmc. 21: 249-56 |
| Wen PY, Yung WK, Lamborn KR, et al. (2006) Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 4899-907 |
| Gschwind HP, Pfaar U, Waldmeier F, et al. (2005) Metabolism and disposition of imatinib mesylate in healthy volunteers. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 33: 1503-12 |
| Dutreix C, Peng B, Mehring G, et al. (2004) Pharmacokinetic interaction between ketoconazole and imatinib mesylate (Glivec) in healthy subjects. Cancer Chemotherapy and Pharmacology. 54: 290-294 |